PAVM - パブメッド (PAVmed Inc.)

PAVMのニュース

   PAVmed Inc.’s (NASDAQ: PAVM) Stock Price Continues To Fall  2022/06/21 13:30:00 Stocks Register
The trading price of PAVmed Inc. (NASDAQ:PAVM) closed lower on Friday, June 17, closing at $0.85, -0.56% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $0.85 and … PAVmed Inc.’s (NASDAQ: PAVM) Stock Price Continues To Fall Read More »
   PAVmed Inc. (NASDAQ: PAVM) Stock: Will It Keep Climbing Higher?  2022/06/01 14:30:00 Marketing Sentinel
In the last trading session, 1.4 million shares of the PAVmed Inc. (NASDAQ:PAVM) were traded, and its beta was 0.27. Most recently the company’s share price was $1.01, and it changed around -$0.05 or -4.72% from the last close, which brings the market valuation of the company to $84.71M. PAVM currently trades at a discount … PAVmed Inc. (NASDAQ: PAVM) Stock: Will It Keep Climbing Higher? Read More »
   PAVmed Inc.’s (PAVM) 4.95% Gain Is A Reason To Reconsider.  2022/05/28 15:30:00 Stocks Register
PAVmed Inc. (NASDAQ:PAVM) price on Friday, May 27, rose 4.95% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.06. A look at the stock’s price movement, the close in the last trading session was $1.01, moving within a range at $1.00 and $1.08. The beta value (5-Year … PAVmed Inc.’s (PAVM) 4.95% Gain Is A Reason To Reconsider. Read More »
   PAVmed Inc.''s (PAVM) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript  2022/05/13 01:19:10 Seeking Alpha
PAVmed Inc. (NASDAQ:NASDAQ:PAVM) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath -…
   PAVmed Non-GAAP EPS of -$0.14 beats by $0.05, revenue of $0.2M misses by $0.15M  2022/05/12 20:49:04 Seeking Alpha
PAVmed press release (PAVM): Q1 Non-GAAP EPS of -$0.14 beats by $0.05.Revenue of $0.2M misses by $0.15M.
   PAVmed Inc. (NASDAQ: PAVM) Stock: Will It Keep Climbing Higher?  2022/06/01 14:30:00 Marketing Sentinel
In the last trading session, 1.4 million shares of the PAVmed Inc. (NASDAQ:PAVM) were traded, and its beta was 0.27. Most recently the company’s share price was $1.01, and it changed around -$0.05 or -4.72% from the last close, which brings the market valuation of the company to $84.71M. PAVM currently trades at a discount … PAVmed Inc. (NASDAQ: PAVM) Stock: Will It Keep Climbing Higher? Read More »
   PAVmed Inc.’s (PAVM) 4.95% Gain Is A Reason To Reconsider.  2022/05/28 15:30:00 Stocks Register
PAVmed Inc. (NASDAQ:PAVM) price on Friday, May 27, rose 4.95% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.06. A look at the stock’s price movement, the close in the last trading session was $1.01, moving within a range at $1.00 and $1.08. The beta value (5-Year … PAVmed Inc.’s (PAVM) 4.95% Gain Is A Reason To Reconsider. Read More »
   PAVmed Inc.''s (PAVM) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript  2022/05/13 01:19:10 Seeking Alpha
PAVmed Inc. (NASDAQ:NASDAQ:PAVM) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath -…
   PAVmed Non-GAAP EPS of -$0.14 beats by $0.05, revenue of $0.2M misses by $0.15M  2022/05/12 20:49:04 Seeking Alpha
PAVmed press release (PAVM): Q1 Non-GAAP EPS of -$0.14 beats by $0.05.Revenue of $0.2M misses by $0.15M.
   PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results  2022/05/12 20:38:00 Business Wire
PAVmed provides business update and preliminary first quarter 2022 financial results.
   PAVmed unit Lucid acquires certain licenses/assets to operate new lab for EsoGuard test  2022/03/03 19:00:59 Seeking Alpha
Lucid Diagnostics'' <> unit LucidDx Labs acquired certain licenses and other related assets from ResearchDx to operate its own new CLIA-certified, CAP-accredited clinical…
   PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth  2022/03/03 13:25:00 Kwhen Finance
   PAVmed picks internal candidate for COO role  2022/02/24 13:49:09 Seeking Alpha
PAVmed (PAVM) appointed Shaun O''Neil as EVP & COO, overseeing diverse corporate operations and commercial activities across the company and its subsidiaries.Mr
   PAVmed Inc. (NASDAQ: PAVM) Is A Buzzing Hot Stock  2022/02/23 14:30:00 Stocks Register
PAVmed Inc. (NASDAQ:PAVM) traded at $1.41 at close of the session on Tuesday, 02/22/22, made a downward move of -4.73% on its previous days price. Looking at the stock we see that its previous close was $1.48 and the beta (5Y monthly) reads 0.12 with the days price range being $1.40 $1.51. In terms PAVmed Inc. (NASDAQ: PAVM) Is A Buzzing Hot Stock Read More »
   PAVmed Inc. (NASDAQ: PAVM) Drops -10.88 Percent In Recent Session, Why Are You Interested?  2022/02/15 16:00:00 Stocks Register
The trading price of PAVmed Inc. (NASDAQ:PAVM) closed lower on Monday, February 14, closing at $1.68, -10.88% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $1.64 and … PAVmed Inc. (NASDAQ: PAVM) Drops -10.88 Percent In Recent Session, Why Are You Interested? Read More »

calendar